B Cell News and Research

RSS
Autoantibody found to cause schizophrenia-like behaviors in mice

Autoantibody found to cause schizophrenia-like behaviors in mice

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

New nanoparticles may pave the way for development of clinical sepsis therapy

New nanoparticles may pave the way for development of clinical sepsis therapy

MIT researchers identify components of mucus that can inhibit fungal infections

MIT researchers identify components of mucus that can inhibit fungal infections

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Persistence of viral RNA following acute infection

Persistence of viral RNA following acute infection

Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma

Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma

New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

Using DNA droplets for early disease detection

Using DNA droplets for early disease detection

Researchers identify predictive biomarkers to fight against non-small cell lung cancer

Researchers identify predictive biomarkers to fight against non-small cell lung cancer

New combination of drugs increases survival time for some patients with refractory lung cancer

New combination of drugs increases survival time for some patients with refractory lung cancer

Study: Nearly 43% of patients with KRAS-mutated lung cancer respond to experimental drug adagrasib

Study: Nearly 43% of patients with KRAS-mutated lung cancer respond to experimental drug adagrasib

Combinations of multiple genetic factors play a role in the broad spectrum of autism

Combinations of multiple genetic factors play a role in the broad spectrum of autism

Computer vision tool effectively distinguishes rheumatoid arthritis from osteoarthritis in joint tissue

Computer vision tool effectively distinguishes rheumatoid arthritis from osteoarthritis in joint tissue

Epidemiology and the public health response of monkeypox

Epidemiology and the public health response of monkeypox

Steady-state DNA motion allows cells to conduct housekeeping tasks under similar nuclear environments

Steady-state DNA motion allows cells to conduct housekeeping tasks under similar nuclear environments

Ibrutinib plus chemoimmunotherapy prolonged progression-free survival in previously untreated mantle cell lymphoma patients

Ibrutinib plus chemoimmunotherapy prolonged progression-free survival in previously untreated mantle cell lymphoma patients

Easily Acquire Expert-Quality Images with the APEXVIEW™ APX100 All-in-One Microscope

Easily Acquire Expert-Quality Images with the APEXVIEW™ APX100 All-in-One Microscope

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.